Tag: drug injury
-
June 2010: FDA Launches Its Postmarketing Drug Safety Evaluations Web Site
New FDA Site Will Include A Summary Analysis Of Recently Reported Adverse Events And Related Medical Articles (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-June 2010 the FDA announced that it will be making…
-
Blood Pressure Medication Benicar (Olmesartan) Might Be Unsafe For Some Patients
Two Clinical Studies Find Patients With Type 2 Diabetes Taking Benicar Had Higher Rate Of Death From A Cardiovascular Cause (Posted by Tom Lamb at DrugInjuryWatch.com) On June 11, 2010 the FDA announced that…
-
June 2010 Update On Several Possible Zocor (Simvastatin) Side Effects
From Myopathy And Rhabdomyolysis To Tendon Ruptures And Interstitial Lung Disease (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce…
-
May 2010: New Safety Information For Xenical And Alli Regarding Cases Of Severe Liver Injury
FDA Had Been Investigating Reports Of Hepatotoxicity Involving Their Active Ingredient, Orlistat, For Past Year (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________ UPDATE: EMA Decides Orlistat Benefits Worth the Risks The CHMP finalized its review…
-
Zithromax-Induced Liver Injury Case Report Where There Was No History Of Liver Problems
Drug-Induced Liver Injury (DILI), Or Toxicity, Can Cause Both Acute And Chronic Liver Disease (Posted by Tom Lamb at DrugInjuryWatch.com) To get our bearings, we start with some points taken from the Abstract for the…
-
April 2010: Senator Chuck Grassley Wants More Independence And Power For FDA Drug-Safety Reviewers
This Idea Has Been Circulating Since The 2005 Grassley-Dodd Bill, With No Real Movement Forward In Past Five Years (Posted by Tom Lamb at DrugInjuryWatch.com) Five years ago, on April 28, 2005, in the…
-
Is Bayer Warning Or Attacking With Its New YAZ / Yasmin Package Insert, Or Label, In The U.S.
Bayer Says YAZ / Yasmin Safety Profile Is Comparable To Older Birth Control Pills, But European Regulators See Possible Increased Risk Of Blood Clot Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: "Bayer…
-
April 2010 Accutane Update: More Medical Evidence Follows A Large Trial Verdict For Drug Injury Victim
New Study Finds Increased Risk Of Developing Ulcerative Colitis; New Jersey Jury Decides Accutane Caused Man's Inflammatory Bowel Disease (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ Update: Roche Wins Reversal of $10.5 Million Accutane…
-
Study About Using Glaxo’s Avodart To Prevent Prostate Cancer Finds Possible Heart Risk
Higher Rate Of Cardiac Failure In Men Taking Avodart (Dutasteride) – 0.7 Percent vs. 0.4 Percent For Those Taking The Placebo (Posted by Tom Lamb at DrugInjuryWatch.com) In the April 1, 2010 edition of…